Resmed Inc
NYSE:RMD

Watchlist Manager
Resmed Inc Logo
Resmed Inc
NYSE:RMD
Watchlist
Price: 246.26 USD 1.09%
Market Cap: 36.1B USD
Have any thoughts about
Resmed Inc?
Write Note

Resmed Inc
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Resmed Inc
Total Liabilities & Equity Peer Comparison

Comparables:
BDX
BSX
SYK
ABT
ISRG

Competitive Total Liabilities & Equity Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
Resmed Inc
NYSE:RMD
Total Liabilities & Equity
$7.2B
CAGR 3-Years
15%
CAGR 5-Years
12%
CAGR 10-Years
12%
Becton Dickinson and Co
NYSE:BDX
Total Liabilities & Equity
$55.6B
CAGR 3-Years
1%
CAGR 5-Years
1%
CAGR 10-Years
16%
Boston Scientific Corp
NYSE:BSX
Total Liabilities & Equity
$38.1B
CAGR 3-Years
6%
CAGR 5-Years
7%
CAGR 10-Years
9%
Stryker Corp
NYSE:SYK
Total Liabilities & Equity
$43.8B
CAGR 3-Years
9%
CAGR 5-Years
10%
CAGR 10-Years
10%
Abbott Laboratories
NYSE:ABT
Total Liabilities & Equity
$73B
CAGR 3-Years
0%
CAGR 5-Years
1%
CAGR 10-Years
6%
Intuitive Surgical Inc
NASDAQ:ISRG
Total Liabilities & Equity
$17.7B
CAGR 3-Years
11%
CAGR 5-Years
14%
CAGR 10-Years
17%

See Also

What is Resmed Inc's Total Liabilities & Equity?
Total Liabilities & Equity
7.2B USD

Based on the financial report for Sep 30, 2024, Resmed Inc's Total Liabilities & Equity amounts to 7.2B USD.

What is Resmed Inc's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
12%

Over the last year, the Total Liabilities & Equity growth was 7%. The average annual Total Liabilities & Equity growth rates for Resmed Inc have been 15% over the past three years , 12% over the past five years , and 12% over the past ten years .

Back to Top